Referred to the Subcommittee on Health.
This bill requires the Secretary of Veterans Affairs to arrange for the National Academies of Sciences, Engineering, and Medicine (NASEM) to review suicides of veterans who received VA care during the five years before enactment. The review must quantify deaths, describe decedents, inventory medications and toxicology findings, examine diagnoses and polypharmacy, evaluate use of non-medication first-line treatments, assess VA mental health staffing, review coordination with State prescription monitoring and medical examiners, identify facilities with high prescription or suicide rates, and recommend improvements.
Whether a study-only approach is sufficient versus immediate reforms.
Relative to its intended legislative type, this bill is a well-scoped statutory study/commission directive with strong specificity about required analytical elements, responsible entities, and report deadlines, but it lacks fiscal authorization, explicit data-access authorities or contingency planning, and sustained implementation follow-up.
This bill requires the Secretary of Veterans Affairs to arrange for the National Academies of Sciences, Engineering, and Medicine (NASEM) to review suicides of veterans who received VA care during the five years before enactment.
The review must quantify deaths, describe decedents, inventory medications and toxicology findings, examine diagnoses and polypharmacy, evaluate use of non-medication first-line treatments, assess VA mental health staffing, review coordination with State prescription monitoring and medical examiners, identify facilities with high prescription or suicide rates, and recommend improvements.
NASEM must complete the review within 180 days of contract entry; the VA must submit and publicly release the report to Congress.
Low-cost, oversight-focused veteran suicide measure with independent review is broadly attractive, but timing, data/privacy, and appropriations uncertainty reduce certainty.
Relative to its intended legislative type, this bill is a well-scoped statutory study/commission directive with strong specificity about required analytical elements, responsible entities, and report deadlines, but it lacks fiscal authorization, explicit data-access authorities or contingency planning, and sustained implementation follow-up.
Whether a study-only approach is sufficient versus immediate reforms.
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether a study-only approach is sufficient versus immediate reforms.
Likely supportive because the bill addresses veteran suicide and potential overmedication and advances transparency.
They will appreciate independent, disaggregated data, attention to non-medication treatments, and mental-health staffing assessments.
They will want stronger, binding follow-up actions and funding for alternatives, since the bill is a study rather than immediate reform.
Generally favorable to an independent, data-driven review that could inform policy.
They will value the NASEM credibility, the clear timelines, and the focus on actionable metrics, while seeking clarity on costs, privacy protections, and avoiding duplication.
They will want a plan to implement recommendations if problems are found.
Skeptical of expanding federal reviews and potential bureaucratic mandates.
They may accept the goal of protecting veterans but worry the bill creates more oversight, threatens clinician autonomy, and lacks limits on data use.
Some conservatives could be open if scope is narrowed and implementation avoids unfunded mandates.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low-cost, oversight-focused veteran suicide measure with independent review is broadly attractive, but timing, data/privacy, and appropriations uncertainty reduce certainty.
The bill has not accumulated any surfaced votes yet.
Whether a study-only approach is sufficient versus immediate reforms.
Low-cost, oversight-focused veteran suicide measure with independent review is broadly attractive, but timing, data/privacy, and appropriat…
Relative to its intended legislative type, this bill is a well-scoped statutory study/commission directive with strong specificity about required analytical elements, responsible entities, and report deadlines, but it l…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.